People's Justice is not a law firm and does not provide legal advice.
Attorney advertising. Prior results do not guarantee a similar outcome.
Do You Qualify?
Eligibility Checklist
- Had an IVC filter implanted (any brand — Bard Recovery, G2, G2X, Eclipse, Meridian, Denali; Cook Günther Tulip or Celect)
- Experienced filter fracture, strut migration, cardiac perforation, organ perforation, pulmonary embolism, DVT, impossible retrieval, or death
- Filter failure documented by imaging (CT scan, X-ray, fluoroscopy) or surgical findings
- Injury occurred within applicable statute of limitations or tolled by MDL participation
IVC filter litigation involves two parallel MDL tracks. Bard MDL 2641 in the District of Arizona has processed over 8,000 cases; Bard's parent company Becton Dickinson assumed all IVC filter liabilities upon its 2017 acquisition of Bard for approximately $24 billion. Cook MDL 2570 in the Southern District of Indiana has handled approximately 5,000 cases, with roughly 1,000–2,000 remaining unresolved as of 2026. The FDA issued safety communications in 2010 and 2014 recommending retrieval of retrievable filters as soon as clinically feasible, and ordered 522 post-market studies whose results confirmed high fracture and perforation rates. No formal recall was ever issued — a regulatory gap exploited by defendants. Discovery rule protections broadly apply because IVC filter fractures are often asymptomatic and discovered only on follow-up imaging.
IVC Filter Lawsuit Settlement Tiers
Settlement values in IVC filter litigation depend primarily on injury severity, surgical intervention required, filter model, and available evidence. Bard's confidential global settlement program uses a tiered grid. Cook cases resolve individually. The following ranges reflect publicly available bellwether verdict data and reported settlement intelligence as of early 2026.
Device Fracture — No Migration
ModerateSettlement Range
Criteria
- IVC filter strut fracture confirmed by imaging
- No documented strut migration beyond vena cava
- No surgical intervention required
- Mild to moderate symptoms (back pain, abdominal discomfort)
Fracture With Migration — No Surgery
SeriousSettlement Range
Criteria
- One or more struts migrated from original position
- Migration documented to retroperitoneum, aorta, or adjacent structures
- Managed without surgical intervention
- Moderate symptoms with documented medical follow-up
Migration Requiring Surgical Removal
SevereSettlement Range
Criteria
- Strut or filter migration requiring open or laparoscopic surgical removal
- High-risk retrieval procedure attempted (endovascular or hybrid)
- Significant documented pain, suffering, and recovery period
- Permanent scarring or functional limitation
Cardiac or Organ Perforation — Death
CatastrophicSettlement Range
Criteria
- Migrated strut penetrated heart wall, pericardium, or vital organ
- Cardiac tamponade, arrhythmia, or emergency cardiac surgery
- Pulmonary embolism caused by filter failure
- Death attributable to IVC filter fracture or migration
Settlement ranges are estimates based on publicly available bellwether verdict data and reported MDL settlement intelligence. Individual case values depend on specific facts, evidence quality, filter model, injury documentation, and applicable law. Past results do not guarantee future outcomes. Consult a qualified attorney for an evaluation of your specific claim.
Who Received IVC Filters: Patient Populations and Exposure Risk
Post-Surgical Patients with Temporary PE Risk
Common Tasks
- Uses ivc filter products or devices as described
- Seeks medical evaluation for related symptoms or injuries
- Consults healthcare provider for ongoing care
- Documents exposure history and medical records
Trauma Patients
Common Tasks
- Uses ivc filter products or devices as described
- Seeks medical evaluation for related symptoms or injuries
- Consults healthcare provider for ongoing care
- Documents exposure history and medical records
Cancer Patients
Common Tasks
- Uses ivc filter products or devices as described
- Seeks medical evaluation for related symptoms or injuries
- Consults healthcare provider for ongoing care
- Documents exposure history and medical records
Elderly Patients with Cardiovascular Comorbidity
Common Tasks
- Uses ivc filter products or devices as described
- Seeks medical evaluation for related symptoms or injuries
- Consults healthcare provider for ongoing care
- Documents exposure history and medical records
Internal Documents & Evidence
Bard Internal Testing Documents: Recovery Filter Fatigue Fracture Data Concealed Pre-Launch
“”
Impact:
FDA 2010 Safety Communication: Adverse Events with Retrievable IVC Filters
“”
Impact:
FDA 2014 Updated Safety Communication: Retrievable IVC Filters Should Be Removed When No Longer Needed
“”
Impact:
Hyde v. C.R. Bard: $3.6 Million Plaintiff Verdict — Key Bellwether Case Summary
“”
Impact:
FDA MAUDE Database: Thousands of IVC Filter Adverse Event Reports
“”
Impact:
FDA Safety Communications and Regulatory Actions on IVC Filters
The FDA issued its first safety communication specifically addressing retrievable IVC filters, citing 921 adverse event reports submitted to MAUDE between 2005 and 2010. The report documented 328 device migrations, 146 embolizations of device components, 70 perforations, and 56 filter fractures. The FDA recommended physicians and patients consider removing retrievable IVC filters as soon as protection from pulmonary embolism was no longer needed. This communication represented the first formal agency acknowledgment that the retrievable filter design class posed distinct long-term risks not present in permanent filter designs.
Following continued adverse event accumulation despite the 2010 warning, the FDA issued an updated safety communication strengthening its retrieval recommendation. The 2014 communication stated that the long-term risks of retrievable IVC filters left in place were not well characterized, and that available evidence suggested the risk-benefit profile favored retrieval once the transient risk of pulmonary embolism had passed. The FDA noted that neither Bard nor Cook had adequately characterized long-term performance in their original 510(k) submissions and that post-market data revealed failure rates exceeding those predicted at clearance.
Between 2015 and 2016, the FDA issued 522 post-market study orders to Bard and Cook requiring prospective clinical data on retrievable filter performance, including fracture, migration, perforation, and retrieval rates. Results posted by 2019 confirmed that fracture and perforation rates far exceeded those represented in original premarket submissions. The 522 study data provided plaintiffs' counsel with manufacturer-generated evidence of the gap between marketed safety claims and actual clinical performance. No recall was issued despite the study findings.
The FDA's Manufacturer and User Facility Device Experience (MAUDE) database reflects thousands of adverse event reports for Bard and Cook IVC filters, including strut fractures, filter migrations, cardiac perforations, and deaths. Expert analysis of MAUDE data submitted in MDL bellwether proceedings established that Bard Recovery and G2 filters generated adverse event report rates substantially higher than competitor devices on a per-unit-implanted basis. MAUDE data, while subject to underreporting bias, provided epidemiological context for the systematic failure pattern that internal Bard testing had predicted before the Recovery filter's 2003 commercial launch.
Discovery in MDL 2641 before Judge David Campbell produced Bard internal engineering and testing documents demonstrating that the Recovery filter exhibited fatigue fracture in bench testing before commercial launch. These documents, combined with the $3.6 million plaintiff verdict in Hyde v. C.R. Bard (affirmed on appeal 2021), drove Becton Dickinson — which acquired Bard in 2017 for approximately $24 billion and assumed all IVC filter liabilities — to enter a confidential global settlement framework with plaintiffs' leadership counsel. As of 2025–2026, most remaining MDL cases are resolving under a settlement grid; new filings continue to be accepted into the settlement program.
Significance Legend
Notable Verdicts & Settlements
Hyde v. C.R. Bard, Inc.
VerdictTinlin v. C.R. Bard, Inc.
VerdictHill v. Cook Medical LLC
VerdictBooker v. C.R. Bard, Inc.
VerdictPavlock v. Cook Medical LLC
VerdictIVC Filter Fracture and Strut Migration
Medical Definition
Mechanical failure of an inferior vena cava filter resulting in the separation of one or more metal struts from the filter body. Fractured struts migrate through the venous system and can lodge in the heart, lungs, kidneys, aorta, or surrounding soft tissue. Migration is frequently asymptomatic until the strut causes perforation, thrombosis, or cardiac injury.
Symptoms
Unexplained back or abdominal pain
CommonChest pain or palpitations
CommonShortness of breath
CommonLeg swelling or DVT symptoms
CommonAsymptomatic (discovered incidentally on imaging)
CommonHematuria (blood in urine) from ureteral perforation
Less CommonRisk Factors
- Bard Recovery or G2 filter model (highest documented fracture rates)
- Cook Celect filter (high caval penetration rates)
- Filter left in place beyond 6 months (retrieval window exceeded)
- Filter placed in younger patients with longer life expectancy
- Prior failed retrieval attempt (increases strut stress)
Treatment Options
Cardiac Tamponade and Pericardial Injury from IVC Filter Migration
Medical Definition
Life-threatening compression of the heart caused by fluid accumulation in the pericardial sac, precipitated by a migrated IVC filter strut penetrating the pericardium or myocardium. The impalement restricts cardiac filling, reduces cardiac output, and can cause hemodynamic collapse requiring emergency intervention.
Symptoms
Severe chest pain radiating to back or left arm
CommonBeck's triad: hypotension, distended neck veins, muffled heart sounds
CommonTachycardia and dyspnea
CommonSyncope or loss of consciousness
Less CommonCardiac arrest
RareRisk Factors
- Bard G2 or Recovery filter with known strut fracture
- Delayed diagnosis of initial filter fracture
- Filter placed suprarenally or near renal veins (proximity to heart)
- Failure of physician to recommend serial imaging after implantation
Treatment Options
Pulmonary Embolism from IVC Filter Failure
Medical Definition
Obstruction of pulmonary arteries by blood clots that bypassed or were generated by a failed IVC filter. Occurs when the filter fails its core purpose — allowing clots to pass through — or when the filter itself becomes a nidus for thrombus formation. A filter that tilts, fractures, or migrates may lose its trapping ability, permitting life-threatening clots to reach the lungs.
Symptoms
Sudden onset chest pain, worse with breathing
CommonSevere shortness of breath and rapid breathing
CommonRapid heart rate (tachycardia)
CommonCoughing up blood (hemoptysis)
Less CommonLightheadedness or syncope
Less CommonSudden death (massive PE)
RareRisk Factors
- IVC filter tilt exceeding 15 degrees reducing trapping efficiency
- Filter fracture creating gaps in filter architecture
- Filter migration changing position and alignment
- Pre-existing hypercoagulable condition
- Failure to transition to anticoagulation therapy when clinically safe
Treatment Options
Your Legal Team
Sarah Keane
Senior Mass Tort Attorney
Sarah Keane has practiced mass tort litigation for 14 years with a concentration in defective medical device cases. She has represented IVC filter injury plaintiffs in both Bard MDL 2641 and Cook MDL 2570, with particular expertise in cases involving cardiac strut migration and complex retrieval procedures. Sarah is based in Phoenix — the home jurisdiction of Bard MDL 2641.
Marcus Webb
Mass Tort Litigation Counsel
Marcus Webb focuses on products liability litigation against medical device manufacturers, with extensive experience in Cook Medical IVC filter cases in the Southern District of Indiana. Based in Indianapolis — the venue for Cook MDL 2570 — Marcus provides clients across the Midwest with direct MDL access and case-specific strategy for Cook Celect and Günther Tulip filter claims.
Diana Reyes
Plaintiff's Trial Counsel
Diana Reyes has handled personal injury and mass tort cases for over a decade, representing IVC filter injury victims across Florida and the Southeast. Florida has one of the highest IVC filter implantation rates in the country due to its large elderly population and concentration of major trauma centers. Diana counsels clients on Florida's 2023 SOL change (HB 837) and its impact on IVC filter filing deadlines.
Frequently Asked Questions
IVC Filter Lawsuit Filing Deadline
In-Depth Guides
C.R. Bard (now Becton Dickinson) manufactured the Recovery, G2, G2X, Eclipse, Meridian, and Denali IVC filters. Internal documents revealed Bard knew of catastrophic fracture rates in the Recovery filter but continued selling it and transitioning to the G2 without disclosure. MDL 2641 in the District of Arizona has processed over 8,000 cases. The Hyde $3.6M verdict is affirmed. A global settlement framework is now active — call today to enroll.
Read guideIVC filter complications range from asymptomatic strut fracture to life-threatening cardiac perforation and pulmonary embolism. Because many fractures are discovered incidentally on imaging, patients may not know their filter has failed. If you have an IVC filter and have not had recent imaging, see a doctor and call us.
Read guideCook Medical manufactured the Günther Tulip and Celect IVC filters. Studies documented high rates of caval penetration with the Celect model. Cook MDL 2570 is in the Southern District of Indiana. Unlike Bard, Cook has not reached a global settlement — your case may go to trial. The Hill v. Cook $460,000 verdict is the benchmark.
Read guideThe most important evidence is imaging confirming filter fracture or strut migration (CT scan, X-ray, or fluoroscopy), your device implant record showing the filter model and lot number, and any treatment records for filter-related complications. You do not need to gather this yourself — our attorneys will request your records directly.
Read guideThe FDA warned in 2010 and again in 2014 that retrievable IVC filters posed serious risks when left in place long-term. Post-market 522 studies ordered in 2015 to 2016 confirmed high fracture and perforation rates. No recall was ever issued — but FDA warnings are powerful evidence of manufacturer knowledge in IVC filter lawsuits.
Read guideMost states allow 2 years from the date you discovered — or should have discovered — your IVC filter failed. MDL registration in Bard MDL 2641 or Cook MDL 2570 tolls your individual state statute of limitations. Florida's SOL dropped from 4 years to 2 years in 2023. Do not wait: call today for a free statute of limitations analysis.
Read guideRetrievable IVC filters were designed to be temporary, but many became permanently embedded — struts penetrating vessel walls or the heart, making standard retrieval impossible. High-risk open or hybrid surgical removal is itself a serious injury and a compensable claim. Even if your filter was never removed, fractured struts remaining in place support a lawsuit.
Read guideBard MDL 2641 (D. Ariz.): global settlement program active; most cases resolving under tiered grid; new cases still enrolling. Cook MDL 2570 (S.D. Ind.): no global settlement; approximately 1,000 to 2,000 cases remain unresolved; individual case management orders active. State court clusters active in California, Texas, New Jersey, and New York for Cook cases outside the MDL.
Read guideYou may qualify if you had a Bard or Cook IVC filter and experienced fracture, strut migration, cardiac or organ perforation, pulmonary embolism attributable to filter failure, or a difficult or impossible retrieval procedure. Even if you have no symptoms, imaging showing strut fracture or migration may support a claim. Contact us for a free evaluation.
Read guideNo IVC filter has ever been formally recalled. The FDA issued safety communications in 2010 and 2014 urging filter retrieval, and ordered post-market 522 studies that confirmed high fracture and perforation rates. The absence of a recall does not mean the devices were safe — the MDL discovery record establishes decades of concealed defect data.
Read guideBard's global settlement program uses a tiered grid: minor fracture cases start around $25,000 to $100,000; fractures requiring surgical removal reach $150,000 to $400,000; cardiac perforation and death cases may exceed $400,000 to $750,000. Cook has no global settlement — values depend on individual case strength and trial risk. Bellwether verdicts anchor valuations: Hyde $3.6M, Tinlin $1.59M, Hill (Cook) $460K.
Read guideIVC filter fractures are frequently asymptomatic. Warning signs include unexplained back or abdominal pain, chest pain, heart palpitations, and shortness of breath. The only definitive test is imaging. If you have an IVC filter and have not had recent follow-up CT or X-ray, request imaging from your doctor and call us for a free consultation.
Read guideState-Specific Information
Sources & References
- —
- —
- —
- —
- —
- —
- —